An allosteric modulator binds to a conformational hub in the β2 adrenergic receptor

被引:54
|
作者
Liu, Xiangyu [1 ,2 ]
Kaindl, Jonas [3 ]
Korczynska, Magdalena [4 ]
Stoessel, Anne [3 ]
Dengler, Daniela [3 ]
Stanek, Markus [3 ]
Huebner, Harald [3 ]
Clark, Mary J. [5 ]
Mahoney, Jake [5 ]
Matt, Rachel Ann [6 ]
Xu, Xinyu [2 ,7 ]
Hirata, Kunio [8 ,9 ]
Shoichet, Brian K. [4 ]
Sunahara, Roger K. [5 ]
Kobilka, Brian K. [2 ,6 ,7 ]
Gmeiner, Peter [3 ]
机构
[1] Tsinghua Univ, Sch Pharmaceut Sci, Beijing, Peoples R China
[2] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China
[3] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Med Chem, Erlangen, Germany
[4] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA
[5] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA
[6] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA
[7] Tsinghua Univ, Sch Med, Beijing, Peoples R China
[8] RIKEN SPring 8 Ctr Sayo Gun, SR Life Sci Instrumentat Unit, Res Infrastruct Grp, Adv Photon Technol Div, Sayo, Hyogo, Japan
[9] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan
关键词
DENSITY-FUNCTIONAL THEORY; G-PROTEIN; STRUCTURAL INSIGHTS; PK(A) PREDICTION;
D O I
10.1038/s41589-020-0549-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most drugs acting on G-protein-coupled receptors target the orthosteric binding pocket where the native hormone or neurotransmitter binds. There is much interest in finding allosteric ligands for these targets because they modulate physiologic signaling and promise to be more selective than orthosteric ligands. Here we describe a newly developed allosteric modulator of the beta(2)-adrenergic receptor (beta(2)AR), AS408, that binds to the membrane-facing surface of transmembrane segments 3 and 5, as revealed by X-ray crystallography. AS408 disrupts a water-mediated polar network involving E122(3.41) and the backbone carbonyls of V206(5.45) and S207(5.46). The AS408 binding site is adjacent to a previously identified molecular switch for beta(2)AR activation formed by I-3.40, P-5.50 and F-6.44. The structure reveals how AS408 stabilizes the inactive conformation of this switch, thereby acting as a negative allosteric modulator for agonists and positive allosteric modulator for inverse agonists.
引用
收藏
页码:749 / +
页数:12
相关论文
共 50 条
  • [21] Agonist-induced conformational changes in the β2 adrenergic receptor
    Kobilka, BK
    JOURNAL OF PEPTIDE RESEARCH, 2002, 60 (06): : 317 - 321
  • [22] Allosteric regulation of the conformational dynamics of a cavitand receptor
    Yan, Zhiqing
    Chang, Yuning
    Mayo, Dennis
    Maslak, Veselin
    Xia, Shijing
    Badjic, Jovica D.
    ORGANIC LETTERS, 2006, 8 (17) : 3697 - 3700
  • [23] A missense mutation in the seven-transmembrane domain of the human Ca2+ receptor converts a negative allosteric modulator into a positive allosteric modulator
    Hu, Jianxin
    Jiang, Jiankang
    Costanzi, Stefano
    Thomas, Craig
    Yang, Wu
    Feyen, Jean H. M.
    Jacobson, Kenneth A.
    Spiegel, Allen M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (30) : 21558 - 21565
  • [24] Deconstruction of the α4β2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Desformylflustrabromine
    German, Nadezhda
    Kim, Jin-Sung
    Jain, Atul
    Dukat, Malgorzata
    Pandya, Anshul
    Ma, Yilong
    Weltzin, Maegan
    Schulte, Marvin K.
    Glennon, Richard A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7259 - 7267
  • [25] Positive allosteric modulator of the human 5-HT2C receptor
    Bin Im, W
    Chio, CL
    Alberts, GL
    Dinh, DM
    MOLECULAR PHARMACOLOGY, 2003, 64 (01) : 78 - 84
  • [26] A Negative Allosteric Modulator of WNT Receptor Frizzled 4 Switches into an Allosteric Agonist
    Riccio, Gennaro
    Bottone, Sara
    La Regina, Giuseppe
    Badolati, Nadia
    Passacantilli, Sara
    Rossi, Giovanni Battista
    Accardo, Antonella
    Dentice, Monica
    Silvestri, Romano
    Novellino, Ettore
    Stornaiuolo, Mariano
    BIOCHEMISTRY, 2018, 57 (05) : 839 - 851
  • [27] Cannabidiol is a negative allosteric modulator at the μ opioid (MOP) receptor
    Kathmann, M
    Flau, K
    Schlicker, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R35 - R36
  • [28] ALLOSTERIC INTERACTIONS AND MODULATOR REQUIREMENT FOR NMDA RECEPTOR FUNCTION
    MARVIZON, JC
    BAUDRY, M
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (02): : 165 - 175
  • [29] Baclofen is an allosteric modulator of the CXCR4 receptor
    Guyon, Alice
    M S-MEDECINE SCIENCES, 2014, 30 (01): : 9 - 12
  • [30] Trifluoroacetate is an allosteric modulator with selective actions at the glycine receptor
    Tipps, Megan E.
    Iyer, Sangeetha V.
    Mihic, S. John
    NEUROPHARMACOLOGY, 2012, 63 (03) : 368 - 373